PNQIN Spring 2026 Summit

May 13, 2026

Claiming Credit for Session
Thank you for attending PNQIN's Summit meeting on May 13, 2026. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to take an evaluation to claim your credit on the following page.

Educational Needs Addressed
In this meeting, PNQIN reviewed the latest updates in OBGYN care including data analyzation, current state and federal policies, how to improve patient-centered education and how to apply evidence-based guidelines. The goal is to improve attendees understanding of maternal and neonatal care and improving treatment for patients and families.

Target Audience

PNQIN providers including physicians, physician assistants, nurses, nurse practitioners, midwives, psychologists, and social workers.

Learning Objectives

At the completion of this activity participants will be better able to:

  • Utilize current maternal and neonatal data to assess gaps in care and guide quality improvement initiatives.
  • Integrate updated state and federal policies and regulations into clinical practice for the care of pregnant individuals,
  • Evaluate and implement strategies to improve equity, safety, and patient-centered care, including effective communication, care transitions, and interdisciplinary coordination.
  • Incorporate evidence-based practices for emerging maternal and neonatal clinical challenges, including vaccination updates, neonatal respiratory care, and neonatal opioid withdrawal syndrome.
  • Develop and implement system-level improvements through collaboration, quality improvement methodologies, and alignment with statewide initiatives and legislative changes.
Course summary
Available credit: 
  • 6.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 2.00 MA Opioid Education Statement
    • 5.25 MA Risk Management
  • 6.00 ANCC
    • 2.00 ANCC Pharmacology
  • 6.00 Social Work (ACE)
  • 6.00 Participation
Course opens: 
05/13/2026
Course expires: 
06/30/2026
Event starts: 
05/13/2026 - 8:30am EDT
Event ends: 
05/13/2026 - 4:30pm EDT
Add to calendar: 
Rating: 
0
Four Points by Sheraton
1125 Boston Providence Turnpike
Norwood 02062
United States

Faculty Presenters and Disclosures
The following speakers have no relevant financial relationships to disclose:
Anna Bralow, Allison Bryant, Jessie Colbert, Ivana Culic, Desiree Decoo, Elaine Rebecca Skye Herman Fitzgerald Lewis, Angela Fowler, Karissa Giovanni, Daphne Remy Gomes, Nicole Grady, Jessica Gray, Traci Green, Janet Guarino, Munish Gupta, Uruj Haider, Marissa Hauptman, Ronald Iverson, Laura Kattan, Andrea Kelley, Cathryn Kokonowski, Sarah Krinsky, Brooke LaMere, Karen R. McAlmon, Alex Procaskey, Tanya Rapinchuk, Julia Reddy, Kimberly Shapiro, Rebecca Skye Herman, Jessica Slusarski, and Elisha Wachman.

Off-Label Discussion
Zuzanna Kubicka and Phaedra Moore will discuss the use of LMA devices for surfactant administration

All other faculty members do not plan on discussing the unlabeled/investigational use of any commercial products. 

Planning Committee and Disclosures
The following planning committee members have no relevant financial relationships to disclose:
Molly Fraust-Wylie, Patient & Family Engagement Coordinator; Ronald Iverson, MD, MPH, Co-Chair, Course Director; Andrea Kelley, LICSW, Social Work Advisor; Kristie Leeman, MD, Co-Chair; Genevieve Lemaire, Project Manager; Emilia Mannstadt, Project Coordinator; Mimi Pomerleau, DNP, Co-Chair, Nurse Planner; Christin Price, MD, Administrative Director, Cheryl Slater, MSN-ED, Co-Chair; Kali Vitek Espinola, MPH, Senior Project Manager.

Dr. Healy, program planner and speaker, receives grant support from Chiesi, USA and is a consultant for Aerogen Pharma.

Dr. Tiffany Moore-Simas receives grant research support from Perigee and is a speaker for Miller Medical Communications.

Accreditor Disclosures
The following planning committee members from Boston University Chobanian & Avedisian School of Medicine’s Office of Continuing Medical Education have no relevant financial relationships to disclose: Michael Burk, BS – Senior Program Operations Manager.

 

Poster Disclosures
The following planning committee members have no relevant financial relationships to disclose:
Rokiah Al Aloussi, Sophie J Berard, Kimberley Campbell, Mary Clough, Ivana Culic, Sue Ghosh, Laurie Huang, Briana Jurkowski, Kettie Louis, Megan Miller, Nancy Mizzoni, Audrey Montgomery, Tierney Morrison, Joe Panerio-Langer, Elisabeth Peterson, Isabel Perez, Alyssa Pochka, Jennifer Roberts-Barry, Olga Valdman, Rachel Vanderkruik, and Marcia Van Vleet.

Cheryl Clark discloses she owns stock in Doximity.

Tiffany A. Moore Simas is a consultant for ACOG, the AIM PMHC Bundle, and IHI PMHC Change Package. Her institution receives grant research support from Lifeline for Moms. She also receives direct grant research support from the CDC, CDC Foundation, NIMH, PCORI, ACOG. Her poster will include off-label discussion.

Robert W. Rothstein owns Stock in ECM Therapeutics.

Exhibitors
This activity has been provided in part by exhibits from: 
Betsy Lehman Center for Patient Safety; Boston Children's Hospital, Pediatric Environmental Health Center; FIRST Steps Together, Jewish Family & Children's Service; Flourish Care; Institute for Health & Recovery, Inc.; March of Dimes; Mass Health; McPAP for Moms(Massachusetts Child Psychiatry Access Program); New England Doula Support; Partner to Decide; Perinatal Neonatal Quality Improvement Network (PNQIN); Prolacta, Root + Rise Perinatal Health; and Stryker.

Joint Accreditation
In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and Perinatal Neonatal Quality Improvement Network (PNQIN). Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME Accreditation 
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 6 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Accreditation
Contact Hours: 6, of which 2 hours is pharmacology worthy.

Social Work Accreditation 
As a Jointly Accredited Organization, Boston University Chobanian & Avedisian School of Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 6 continuing education credits.

Opioid Education/Pain Management Training
This program meets the criteria of the Massachusetts Board of Registration in Medicine for 2 hours of opioid education.

Risk Management Training
This program meets the criteria of the Massachusetts Board of Registration in Medicine for 5.25 hours of risk management education.

Available Credit

  • 6.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 2.00 MA Opioid Education Statement
    • 5.25 MA Risk Management
  • 6.00 ANCC
    • 2.00 ANCC Pharmacology
  • 6.00 Social Work (ACE)
  • 6.00 Participation
Please login or register to take this course.